Literature DB >> 25669443

Differences in HPV Immunization Levels Among Young Adults in Various Regions of the United States.

Mahbubur Rahman1, Momin Islam, Abbey B Berenson.   

Abstract

HPV vaccine uptake in young adult women in the Southern US has been previously found to be the lowest in the country. In addition, geographic variation with regard to HPV vaccination among young adult men has not been investigated yet. The objective of this study was to use the most recent data to determine if inequality still exists. We used Behavioral Risk Factor Surveillance System 2012 data from 8 states (no data available from Midwest) to examine the geographic variations in weighted proportion of adults who initiated (≥ 1 dose) and completed (3 doses) the HPV vaccine among 3727 young adults (2014 women and 1713 men) 18-26 years old based on self-reported HPV vaccination and socio-demographic characteristics. The weighted vaccine initiation and completion rates among men were: 6.3 and 1.7% overall, 8.5 and 2.2% in the Northeast, 6.7 and 1.6% in the West, and 4.9 and 1.4% in the South (p = 0.184 and 0.774). The rates among women were: 40.4% and 27.4, 58.7 and 45.6%, 39.0 and 24.8%, and 30.4 and 17.7% in the respective regions (p < 0.001 for both). Adjusted multivariable logistic regression showed that women living in the South and West were less likely to initiate and complete the 3-dose HPV vaccine series when compared to those in the Northeast. Despite an increase in HPV vaccine uptake among young adult women in all regions, geographic disparity still exists. Moreover, young adult men had very low HPV vaccine initiation and completion rates throughout the US.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25669443     DOI: 10.1007/s10900-015-9995-2

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  19 in total

1.  Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital.

Authors:  Nicholas H Schluterman; Mishka Terplan; Alison D Lydecker; J Kathleen Tracy
Journal:  Vaccine       Date:  2011-04-06       Impact factor: 3.641

2.  Geographic variation in human papillomavirus vaccination uptake among young adult women in the United States during 2008-2010.

Authors:  Mahbubur Rahman; Tabassum H Laz; Abbey B Berenson
Journal:  Vaccine       Date:  2013-09-23       Impact factor: 3.641

Review 3.  Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease.

Authors:  Charles J N Lacey; Catherine M Lowndes; Keerti V Shah
Journal:  Vaccine       Date:  2006-08-31       Impact factor: 3.641

4.  Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.

Authors:  Meg Watson; Mona Saraiya; Faruque Ahmed; Cheryll J Cardinez; Marsha E Reichman; Hannah K Weir; Thomas B Richards
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

5.  Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Authors:  Suzanne M Garland; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Diane M Harper; Sepp Leodolter; Grace W K Tang; Daron G Ferris; Marc Steben; Janine Bryan; Frank J Taddeo; Radha Railkar; Mark T Esser; Heather L Sings; Micki Nelson; John Boslego; Carlos Sattler; Eliav Barr; Laura A Koutsky
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

6.  Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007.

Authors:  Nidhi Jain; Gary L Euler; Abigail Shefer; Pengjun Lu; David Yankey; Lauri Markowitz
Journal:  Prev Med       Date:  2008-12-06       Impact factor: 4.018

Review 7.  Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions.

Authors:  Anna R Giuliano; Guillermo Tortolero-Luna; Elena Ferrer; Ann N Burchell; Silvia de Sanjose; Susanne Kruger Kjaer; Nubia Muñoz; Mark Schiffman; F Xavier Bosch
Journal:  Vaccine       Date:  2008-08-19       Impact factor: 3.641

8.  Human papillomavirus vaccine uptake among 18- to 26-year-old women in the United States: National Health Interview Survey, 2010.

Authors:  Tabassum H Laz; Mahbubur Rahman; Abbey B Berenson
Journal:  Cancer       Date:  2012-11-26       Impact factor: 6.860

9.  Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization.

Authors:  Chun Chao; Christine Velicer; Jeff M Slezak; Steven J Jacobsen
Journal:  Am J Epidemiol       Date:  2010-01-04       Impact factor: 4.897

10.  Human papillomavirus vaccine uptake among 9-17 year old males in the United States: the National Health Interview Survey, 2010.

Authors:  Tabassum H Laz; Mahbubur Rahman; Abbey B Berenson
Journal:  Hum Vaccin Immunother       Date:  2013-01-07       Impact factor: 3.452

View more
  14 in total

1.  Does Self-Efficacy Mediate the Relationships Between Social-Cognitive Factors and Intentions to Receive HPV Vaccination Among Young Women?

Authors:  Shannon M Christy; Joseph G Winger; Catherine E Mosher
Journal:  Clin Nurs Res       Date:  2017-11-14       Impact factor: 2.075

2.  Regional variations in human papillomavirus prevalence across time in NHANES (2003-2014).

Authors:  Jacqueline M Hirth; Yong-Fang Kuo; Jonathan M Starkey; Richard E Rupp; Tabassum H Laz; Mahbubur Rahman; Abbey B Berenson
Journal:  Vaccine       Date:  2019-06-07       Impact factor: 3.641

3.  Factors Associated with Increased HPV Vaccine Use in Rural-Frontier U.S. States.

Authors:  Djin Lai; Qian Ding; Julia Bodson; Echo L Warner; Deanna Kepka
Journal:  Public Health Nurs       Date:  2015-08-31       Impact factor: 1.462

4.  HPV vaccine uptake among overweight and obese US adolescents: An analysis of the National Health and Nutrition Examination Survey (NHANES) 2009-2014.

Authors:  Maria E Sundaram; Susan M Mason; Nicole E Basta
Journal:  Vaccine       Date:  2016-03-25       Impact factor: 3.641

5.  Geographic Variation in Human Papillomavirus Vaccination Initiation and Completion Among Young Adults in the U.S.

Authors:  Eric Adjei Boakye; Oluwole A Babatunde; Maggie Wang; Nosayaba Osazuwa-Peters; Wiley Jenkins; Minjee Lee; Minjin Kim
Journal:  Am J Prev Med       Date:  2020-12-17       Impact factor: 5.043

6.  HPV vaccination initiation after the routine-recommended ages of 11-12 in the United States.

Authors:  Daniel C Beachler; Felisa A Gonzales; Sarah C Kobrin; Aimée R Kreimer
Journal:  Papillomavirus Res       Date:  2016-12-01

7.  A multimodal approach to improving human papillomavirus vaccination in a community pharmacy setting.

Authors:  Kenneth C Hohmeier; Donna D Randolph; Cindy Taliaferro Smith; Tracy M Hagemann
Journal:  SAGE Open Med       Date:  2016-12-14

8.  Area-Level Variation and Human Papillomavirus Vaccination among Adolescents and Young Adults in the United States: A Systematic Review.

Authors:  Elizabeth K Do; Brianna Rossi; Carrie A Miller; Albert J Ksinan; David C Wheeler; Askar Chukmaitov; John W Cyrus; Bernard F Fuemmeler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-10-02       Impact factor: 4.090

9.  Pharmacists' Attitudes and Perceived Barriers to Human Papillomavirus (HPV) Vaccination Services.

Authors:  Tessa J Hastings; Lindsey A Hohmann; Stuart J McFarland; Benjamin S Teeter; Salisa C Westrick
Journal:  Pharmacy (Basel)       Date:  2017-08-07

10.  Evaluation of Human Papillomavirus Vaccination After Pharmacist-Led Intervention: A Pilot Project in an Ambulatory Clinic at a Large Academic Urban Medical Center.

Authors:  Julianna Cebollero; Suzanne M Walton; Laurie Cavendish; Kristi Quairoli; Carrie Cwiak; Melissa J Kottke
Journal:  Public Health Rep       Date:  2020-03-30       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.